Page last updated: 2024-10-30

beta-lapachone and Carcinoma, Squamous Cell

beta-lapachone has been researched along with Carcinoma, Squamous Cell in 2 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeon, YJ1
Bang, W1
Shin, JC1
Park, SM1
Cho, JJ1
Choi, YH1
Seo, KS1
Choi, NJ1
Shim, JH1
Chae, JI1
Boothman, DA1
Greer, S1
Pardee, AB1

Other Studies

2 other studies available for beta-lapachone and Carcinoma, Squamous Cell

ArticleYear
Downregulation of Sp1 is involved in β-lapachone-induced cell cycle arrest and apoptosis in oral squamous cell carcinoma.
    International journal of oncology, 2015, Volume: 46, Issue:6

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; D

2015
Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.
    Cancer research, 1987, Oct-15, Volume: 47, Issue:20

    Topics: Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; DNA Rep

1987